PLASTIC21 Apr Understanding Breast Implant Illness and Surgical Management
Breast Implant Illness (BII) is a term used by patients and clinicians to describe a constellation of systemic symptoms believed to be associated with breast implants. While not formally classified as a singular medical diagnosis, growing patient reports have led to increased research and awareness surrounding the condition.
Symptoms attributed to BII vary widely and may include chronic fatigue, joint pain, brain fog, hair thinning, autoimmune-like reactions, and generalized inflammation. Some patients also report anxiety, sleep disturbances, and skin rashes. Because these symptoms overlap with other medical conditions, diagnosis often requires comprehensive evaluation.
For patients who suspect implant-related illness, explant surgery is frequently pursued as both a diagnostic and therapeutic step. Removal of the implant — often combined with total capsulectomy — aims to eliminate potential inflammatory triggers within the body.
The surgical technique known as “en bloc capsulectomy” involves removing the implant and capsule together in one intact unit when medically appropriate. However, surgical approach varies depending on capsule thickness, implant integrity, and anatomical safety considerations.
At PHI Surgery in Montreal, Dr. Perry Gdalevitch conducts detailed consultations for patients presenting with BII concerns. Surgical planning prioritizes complete implant removal while preserving surrounding tissue health.
Post-explant recovery includes both physical and systemic monitoring. Some patients report gradual symptom improvement following implant removal, though timelines vary individually.
Breast Implant Illness remains an evolving field of study, but explant surgery provides a pathway for patients seeking clarity, relief, and physiologic reset.
